BG Medicine Inc (NASDAQ:BGMD)

Data as of Sep 15
 -0.0215 / -3.11%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

BG Medicine, Inc. is a life sciences company, which is focused on the discovery, development and commercialization of novel cardiovascular diagnostics to address significant unmet medical needs, improve patient outcomes and contain healthcare costs. The company is commercializing two diagnostic tests, which are marketed under the brand names BGM Galectin-3 and CardioSCORE. BG Medicine was founded by Noubar B. Afeyan on February 9, 2000 and is headquartered in Waltham, MA.

Contact Information

BG Medicine, Inc.
610 North Lincoln Street
Waltham Massachusetts 02451-2188
P:(781) 890-1199
Investor Relations:



Other institutional6.53%
Mutual fund holders6.43%
Individual stakeholders32.77%

Top Executives

Paul R. SohmerPresident, Chief Executive Officer & Director
Anastasia RaderSenior VP-Executive Operations & Human Resources
Stephen P. HallChief Financial Officer & Executive Vice President
Aram S. AdourianChief Scientific Officer & Senior Vice President
Carol A. AdilettoVice President-Clinical & Regulatory Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.